1. Home
  2. RDHL vs PETZ Comparison

RDHL vs PETZ Comparison

Compare RDHL & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • PETZ
  • Stock Information
  • Founded
  • RDHL 2009
  • PETZ 2002
  • Country
  • RDHL Israel
  • PETZ China
  • Employees
  • RDHL N/A
  • PETZ N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • PETZ Steel/Iron Ore
  • Sector
  • RDHL Health Care
  • PETZ Industrials
  • Exchange
  • RDHL Nasdaq
  • PETZ Nasdaq
  • Market Cap
  • RDHL 11.2M
  • PETZ 12.9M
  • IPO Year
  • RDHL N/A
  • PETZ 2017
  • Fundamental
  • Price
  • RDHL $7.15
  • PETZ $1.20
  • Analyst Decision
  • RDHL
  • PETZ
  • Analyst Count
  • RDHL 0
  • PETZ 0
  • Target Price
  • RDHL N/A
  • PETZ N/A
  • AVG Volume (30 Days)
  • RDHL 14.3K
  • PETZ 20.8K
  • Earning Date
  • RDHL 11-19-2024
  • PETZ 11-26-2024
  • Dividend Yield
  • RDHL N/A
  • PETZ N/A
  • EPS Growth
  • RDHL N/A
  • PETZ N/A
  • EPS
  • RDHL N/A
  • PETZ N/A
  • Revenue
  • RDHL $3,707,000.00
  • PETZ $3,175,809.00
  • Revenue This Year
  • RDHL $224.90
  • PETZ N/A
  • Revenue Next Year
  • RDHL $82.69
  • PETZ N/A
  • P/E Ratio
  • RDHL N/A
  • PETZ N/A
  • Revenue Growth
  • RDHL N/A
  • PETZ 2.49
  • 52 Week Low
  • RDHL $6.80
  • PETZ $0.89
  • 52 Week High
  • RDHL $82.00
  • PETZ $1.74
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 29.71
  • PETZ 42.21
  • Support Level
  • RDHL $7.98
  • PETZ $1.20
  • Resistance Level
  • RDHL $7.36
  • PETZ $1.30
  • Average True Range (ATR)
  • RDHL 0.37
  • PETZ 0.06
  • MACD
  • RDHL -0.12
  • PETZ -0.01
  • Stochastic Oscillator
  • RDHL 0.00
  • PETZ 5.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About PETZ TDH Holdings Inc.

TDH Holdings Inc is engaged in the business of manufacturing and selling of petfood and restaurant operations. The company has two operating segments which include Petfood sales and Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.

Share on Social Networks: